405 related articles for article (PubMed ID: 11718560)
1. Defining the molecular basis of Arf and Hdm2 interactions.
Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
[TBL] [Abstract][Full Text] [Related]
2. Intrinsically unstructured domains of Arf and Hdm2 form bimolecular oligomeric structures in vitro and in vivo.
Sivakolundu SG; Nourse A; Moshiach S; Bothner B; Ashley C; Satumba J; Lahti J; Kriwacki RW
J Mol Biol; 2008 Dec; 384(1):240-54. PubMed ID: 18809412
[TBL] [Abstract][Full Text] [Related]
3. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
[TBL] [Abstract][Full Text] [Related]
4. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein.
DiGiammarino EL; Filippov I; Weber JD; Bothner B; Kriwacki RW
Biochemistry; 2001 Feb; 40(8):2379-86. PubMed ID: 11327858
[TBL] [Abstract][Full Text] [Related]
6. ARF function does not require p53 stabilization or Mdm2 relocalization.
Korgaonkar C; Zhao L; Modestou M; Quelle DE
Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
[TBL] [Abstract][Full Text] [Related]
7. Peptides derived from two dynamically disordered proteins self-assemble into amyloid-like fibrils.
Bothner B; Aubin Y; Kriwacki RW
J Am Chem Soc; 2003 Mar; 125(11):3200-1. PubMed ID: 12630860
[TBL] [Abstract][Full Text] [Related]
8. p14ARF interacts with DAXX: effects on HDM2 and p53.
Ivanchuk SM; Mondal S; Rutka JT
Cell Cycle; 2008 Jun; 7(12):1836-50. PubMed ID: 18583933
[TBL] [Abstract][Full Text] [Related]
9. Abundant expression of spliced HDM2 in Hodgkin lymphoma cells does not interfere with p14(ARF) and p53 binding.
Stürzenhofecker B; Schlott T; Quentin T; Kube D; Jung W; Trümper L
Leuk Lymphoma; 2003 Sep; 44(9):1587-96. PubMed ID: 14565663
[TBL] [Abstract][Full Text] [Related]
10. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.
Clark PA; Llanos S; Peters G
Oncogene; 2002 Jul; 21(29):4498-507. PubMed ID: 12085228
[TBL] [Abstract][Full Text] [Related]
11. DNA damage disrupts the p14ARF-B23(nucleophosmin) interaction and triggers a transient subnuclear redistribution of p14ARF.
Lee C; Smith BA; Bandyopadhyay K; Gjerset RA
Cancer Res; 2005 Nov; 65(21):9834-42. PubMed ID: 16267006
[TBL] [Abstract][Full Text] [Related]
12. The Short N-Terminal Repeats of Transcription Termination Factor 1 Contain Semi-Redundant Nucleolar Localization Signals and P19-ARF Tumor Suppressor Binding Sites.
Boutin J; Lessard F; Tremblay MG; Moss T
Yale J Biol Med; 2019 Sep; 92(3):385-396. PubMed ID: 31543703
[TBL] [Abstract][Full Text] [Related]
13. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.
Rizos H; Darmanian AP; Mann GJ; Kefford RF
Oncogene; 2000 Jun; 19(26):2978-85. PubMed ID: 10871849
[TBL] [Abstract][Full Text] [Related]
14. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
Tago K; Chiocca S; Sherr CJ
Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
[TBL] [Abstract][Full Text] [Related]
15. CARF binds to three members (ARF, p53, and HDM2) of the p53 tumor-suppressor pathway.
Kamrul HM; Wadhwa R; Kaul SC
Ann N Y Acad Sci; 2007 Apr; 1100():312-5. PubMed ID: 17460193
[TBL] [Abstract][Full Text] [Related]
16. The CBP/p300 TAZ1 domain in its native state is not a binding partner of MDM2.
Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochem J; 2004 Aug; 381(Pt 3):685-91. PubMed ID: 15154850
[TBL] [Abstract][Full Text] [Related]
17. Contribution of two independent MDM2-binding domains in p14(ARF) to p53 stabilization.
Lohrum MA; Ashcroft M; Kubbutat MH; Vousden KH
Curr Biol; 2000 May; 10(9):539-42. PubMed ID: 10801444
[TBL] [Abstract][Full Text] [Related]
18. HDM2 overexpression and focal loss of p14/ARF expression may deregulate the p53 tumour suppressor pathway in meningeal haemangiopericytomas. Study by double immunofluorescence and laser scanning confocal microscopy.
Martínez JC; Palomino JC; Cabello A; Sepúlveda JM; de la Cámara AG; Ricoy JR
Histopathology; 2005 Feb; 46(2):184-94. PubMed ID: 15693891
[TBL] [Abstract][Full Text] [Related]
19. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I.
Ayrault O; Karayan L; Riou JF; Larsen CJ; Séité P
Oncogene; 2003 Apr; 22(13):1945-54. PubMed ID: 12673200
[TBL] [Abstract][Full Text] [Related]
20. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
